centerforbiosimilars14h
Biosimilars Rheumatology Roundup: January 2025
January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...
Pharmabiz16h
Celltrion’s Avtozma, a biosimilar to Actemra receives US FDA approval to treat RA, GCA, pJIA, sJIA and Covid-19
Jersey City, New Jersey Saturday, February 1, 2025, 16:00 Hrs [IST] ...